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EMENTS in the techniques of 
n procurement and surgical graft-
the introduction of cyclosporine (Cs) 
)cd to improvements in results after 
" liver transplantation.: The J-year 
rate after pediatric liver transplanta-
. !lOW exceeds 70%. This retrospective 
represents an analysis of the causes of 
after pediatric liver transplantation. 
PATIENTS AND METHODS 
twenty-seven patients underwent liver 
_,,,,H.lUll between March 1980 and February 1986 
Children's Hospital in Pittsburgh. Sixty-three 
received two liver transplants. and 14 patients 
three transplants. The age range of the patients 
3 weeks to 18 years (mean. 6.11 vears). The etiology 
patients' liver disease is shown in Table 1. All 
were treated with a combtnation of Cs and 
. of the 227 patients died during the study 
were 31 males and 39 females with an age 
5 months to 18 years (mean. 6.07 ± 0.6 years). 
of the liver disease of the patients who died is 
in Table J. 
patients who died in the immediate perioperative 
(ie. intraoperative or within 24 hours) and five 
who died outside of Pittsburgh were excluded 
the analysis. Forty-three of the remaining 61 
who died were subjected to a postmortem exami-
. The cause of death in these patieni~ was based on 
available clinical information as well as the autopsv 
. The cause of death in the remaining 18 patients 
based on the available clinical information only. 
the cause of death after liver transplantation 
often multifactorial. an attempt was made, based on 
available informallon. to identify the primary cause of 
RESULTS 
was the primary cause of 
in 26 patients and was related to throm-
of the hepatic artery in 11 patients. 
ry nonfunction of the graft in ten 
patients, and severe rejection in five patients. 
A further 21 patients died of overwhelming 
sepsis, Opportunistic infections accounted for 
15 of these deaths and included cytomegalovi-
rus infection in four patients, varicella in two 
patients. aspergillosis in two patients. candida 
infection in two patients. pneumocystis and 
cryptococcus infection in one patient each . 
and a combination of viral and fungal infec-
tion in three patients. Excessive bleeding was 
the primary cause of death in a further seven 
patients and was related to intraoperative 
bleeding during exploratory laparotomy or 
liver retransplantation in four patients and 
rupture of a mycotic aneurysm in three 
patients. The miscellaneous causes of death 
included Iymphoproliferative disease (two 
cases), recurrent hepatoma (one case), infarc-
tion of the small intestine (one case), cardiac 
failure in a patient who received a heart and 
liver transplant (one case), hyperkalemia in 
the postoperative period after a Nissen fundo-
plication (one case), and brain death due to an 
anomalous insertion of the superior vena cava 
into the infrarenal inferior vena cava (one 
case). 
The time interval between the initial liver 
transplant and the death of the patient is 
shown in Table 2. Twenty-eight deaths 
occurred during the first month after the 
initial liver transplant. Liver failure was the 
primary cause of death in 20 of the 28 earlv 
- . 
deaths. All of the deaths due to primary 
From the Deparrmenl of Surgery, UniversiIY of Pills-
burgh Health Center. 
Suppol'led by research grant.< from Iht' Veterans 
Administration and Projecl Granl No. AM-29961 from 
the National/nslitutes of HeaiIh, Belhesda. MD. 
Address reprint requesls to CO. Esquivel, MD, PhD. 
Dt>partment of Surgery, 4 West Falk Clinic. 3601 Fifth 
Ave. Pittsburgh, PA 15213. 
e /988 b.I' Grune & Stratton. Inc. 
0041 -1345/88j200 1 -/21 8$03.00jO 
Transplantation Proceedings, Vol XX. No 1, Suppl 1 (February), 1988: pp 613-615 613 
614 
Table 1 Etiology of tha liver Diseasas Encountered in 
227 Patients Undergoing Liver Transplantation and 
in the 61 Deaths After Liver Transplantation 
Disease 101al Deaths 
Biliary 8tresla/hypoplasla 
Biliary atreSia 107 33 
Alagille's syndrome 13 6 
Metabolic dlSOfderS 
a ,-AntItrypsin deficiency 30 6 
Wilson· s d,sease 6 2 
Glycogen storage d,sease 5 2 
Tyrosinemia 5 2 
Other 2 
CirrhosIs 
Chronic active hepatitis 10 3 
Other 16 
Familial choleslasls 10 4 
Acute hepatIc failure 
Fulminant hepatlt!s 3 3 
Drug Induced 2 2 
Neonatal hepatitIs 7 1 
MIscellaneous 11 6 
nonfunction of the graft occurred in the first 
month after the transplant. The deaths due to 
overwhelming sepsis, especially those due to 
viral infections. occurred after the first month. 
Eighty-five percent of the deaths occurred 
within 6 months of the initial liver transplant. 
and only three deaths occurred after the first 
year. 
Thirty of the 150 patients who received a 
single liver transplant died during the study 
period. However, 24 of the 63 patients who 
Table 2. Time Interval Between the Initial liver 
Transplent and the 08ath of the Patient 
Interval (mol 
Compl""'tlOf1 0-1 1- 3 3-6 6-12 >12 
Liver Failure 
Pnmary nonfunction 10 
Hepatic artery thrombo-
s.s 8 1 
Rejection 2 2 
SepSIS 
Viral 6 2 
BacterIal 2 2 
Funga! 2 
Other 2 
Bleeding 1 5 
MIscellaneous 2 2 2 
underwent liver retransplanlation and 
of the 14 pa lIents who received three 
transplant~ died. 
DISCUSSION 
This retrospective study analyses the 
of death after pediatric liver transpla 
Liver failure was the most common cause 
death after pediatric liver transplantation 
was related to throm bosis of the hepatic 
ry. primary nonfunction of the graft 
severe rejection. Thrombosis of the . 
artery continues to be a problem after 
ric liver transplantation. The etiology is 
ably multifactorial. and further research 
needed before the problem is reso. 
Improvements in assessing the quality of 
liver in the donor, in the technique of· 
ing the donor liver, and in the storage of 
donor liver may decrease the incidence 
primary nonfunction of the graft. 
The phenomenon of accelerated rejection 
the liver is being recognized increaSingly 
may account for some of the patients 
ously labeled as primary nonfunction of 
graft and thrombosis of the hepatic 
Again, further research is needed to fu 
understand and correctly treat this immuno-
logic phenomenon and thus prevent some 
the fatal complications. The introduction 
Cs has been a major factor in the improve-
ment of the results after liver transplantation.2 
However. management of rejection still con-
stitutes a major problem. Too little immuno-
suppression results in a greater incidence of 
rejection. whereas overimmunosuppression in-
creases the risk of opportunistic infections. 
Thus. the introduction of new. selective immu-
nosuppressive agents would prevent rejection 
without the risk of overwhelming sepsis. 
There is a growing realization that liver 
retransplantation in patients with primary 
technical failures or hepatic rejection is fea-
sible. thus further reducing the numbers of 
patients dying posttransplant.3 However, the 
lack of suitable pediatric donors continues to 
be a limiting factor. The use of partiall) 
ver retransplantation 
. and 
: tlents who received h 
ied. t ree 
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adult livers may heip to alle-
problem. However, liver retrans-
was associated with an increased 
. Twenty percent of the patients who 
. one liver transplant died compared 
50% of the patient's who received three 
It is important to identify those patients 
the best chance for survival so as not to 
organs. In patients with a failure of 
or more organ system liver transplanta-
or retransplantation the prognosis is 
y poor, with a survival rate of less 
209(.4 
unistic infection is always a concern 
immunosuppressed patients, particularly 
the dose has been increased to treat 
of rejection 5 Fungal infections. in 
r, are associated with a high mortali-
Fungal infections have been shown to be 
to the use of high-dose steroids for 
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suspected or proved rejection, heavy peropera-
tive blood loss. and prolonged stay in the 
intensive care unit. 
The majority of the dea ths after liver trans-
plantation occurred soon after the transplant. 
Eighty-five percent of the deaths occurred 
within 6 months posttranspJant. whereas only 
three patients who survived longer than I year 
posttransplant died. 
This retrospective analysis has identified 
liver failure due to primary graft nonfunction, 
hepatic artery thrombosis and rejection, and 
overwhelming sepsis, in particular, opportu-
nistic infections, as the major causes of deaths 
after pediatric liver transplantation. Thus. it 
would appear that despite the already superior 
results after pediatric liver transplantation. 
further technical and immunologic improve-
ments could lead to even better survival. 
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